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Lipid Nature and Their Influence on Opening of Redox-active
Liposomes
Martin Loew, Jerimiah C. Forsythe, and Robin L. McCarley*
Department of Chemistry and Center for Biomodular Multi-scale Systems, Louisiana State
University, Baton Rouge, LA 70803-1804

Abstract
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The pathway for contents release from reduction-sensitive liposomes based on a quinonedioleoylphosphatidylethanolamine lipid conjugate (Q-DOPE) was outlined using results from
fluorescent dye contents release assays, as well as single- and multiple-angle light scattering.
Experimental observations are consistent with a shape/size change of the reduced liposomes prior
to their aggregation, with subsequent near-quantitative contents release achieved only when the
lipid membrane experiences conditions favorable to a lamellar to an inverted hexagonal phase
transition. Addition of poly(ethyleneglycol)-modified DOPE (PEG-DOPE) to the Q-DOPE
liposomal formulation results in stabilization of the lipid bilayer, whereas incorporation of DOPE
yields faster contents release. At high DOPE concentrations, DOPE/PEG-DOPE/Q-DOPE
liposomes exhibit larger contents release, indicating a change in pathway for contents release. The
outcomes here provide a better understanding of the underlying principles of triggered liposomal
contents release and the potential utility of specific lipid properties for the rational design of drug
delivery systems based on the novel Q-DOPE lipid.

INTRODUCTION
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Optimization of lipid compositions is a crucial task in the design of liposomal drug delivery
systems. To that end, the dichotomous interplay between liposome stabilizing materials and
those components that enable efficient contents release at the target site has to be
understood. For example, increased blood circulation times can be achieved by stabilizing
the structure of pure phospholipid liposomes and minimizing their removal by the
reticuloendothelial system1 through the incorporation of polymer-grafted lipids2–4 or certain
peptides.5 Thus, the liposomes can accumulate efficiently at bodily target sites having leaky
vasculature and poor lymphatic drainage via the enhanced permeability and retention (EPR)
effect that is exploited in cancer therapy.6 However, use of a liposomal carrier system that
remains stable to release of its encapsulated molecules interferes with the necessity to reveal
the payload in its active form at the target site, unless contents release can be had by
environmental stimuli at that site.
The use of poly(ethyleneglycol)-modified phospatidylethanolamine lipids (PEG-PE) in
making liposomes with increased blood circulation times has resulted in clinically successful
cancer therapies based on the delivery of Doxorubicin from Doxil liposomes.7, 8 Although
release of the chemotherapeutic Doxorubicin from the PEG-based liposomes is thought to
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result from destruction of the chemical gradient used to load them with the drug, the process
is slow.9 As a result, the relatively large amount of required liposomal drug results in side
effects, such as hand-foot syndrome and mucositis in patients.10 In addition, clinicallyrelevant drug release is specific to Doxorubicin.
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Triggerable-delivery liposome systems have been under development in the past 20 years,
with the premise that payload release will occur upon the liposome sensing specific
environments present at its destination. Various non-clinical liposomal formulations can be
triggered, for instance, by low pH,11–13 the presence of thiolytic agents, 7, 8 or enzymatic
action.14–16 Although there are variations in lipid composition and the nature of the
triggering mechanism, many liposomal systems share the same underlying release principle,
namely use of a triggering event to elicit a change in the phase of the lipids composing the
bilayer of the liposome so as to expel the encapsulated contents. For example, a stable
liquid-crystalline lamellar phase (Lα) of a lipid under one set of conditions allows for
formation of liposomes that can be loaded with target molecules. Under the influence of the
specific trigger of choice, the properties of the lipids composing the liposome change to
yield a non-lamellar lipid phase, the production of which leads to payload release. This can
be achieved—with the exception of several pH-sensitive formulations—by the cleavage of
lipid head groups/lipids to generate destabilized membranes typically composed of nonbilayer forming lipids, such as dioleylphosphatidylethanolamine, DOPE,20 or derivatives of
diacylglycerol.7, 8 DOPE, or specific mixtures of DOPE or diacylglycerol with bilayer-prone
lipids, forms inverted micelle hexagonal phases (HII) above its phase transition temperature
TH.21, 22 Therefore, the release of encapsulated molecules is postulated to result from the
Lα→HII phase transformation.12 However, this release mechanism is not yet fully
understood and most likely is specific to the different liposomal systems that rely on
generation of an HII-prone lipid mixture.
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For a rational design of liposomal formulations and control of their properties, knowledge
about the mechanism for a given triggerable system is required. Then, the influence of
specific components on the release mechanism—such as saturated or unsaturated
phospholipids, PEGylated lipids, or other materials that alter phase transition temperatures,
intrinsic curvature of lipid layers, and fluidity of the lipid membranes—can be evaluated.
Following this approach, we report here on investigations of a recently invented, reductionsensitive liposomal system20 that use light scattering and fluorescence contents release
assays. After extracting information about different intermediate stages during the release of
liposomal contents, the effect of added DOPE and PEGylated DOPE diluent lipids was then
determined. A proposed mechanistic model is used to explain the influence of both diluent
lipids on release kinetics and the amount of contents released, thus giving insights in their
potential role in drug delivery systems.

EXPERIMENTAL PROCEDURES
Materials and Vesicle Preparation
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DOPE, and the ammonium salt of 1,2dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(poly(ethylene glycol))-2000],
PEG2000-DOPE (Avanti Polar Lipids; Alabaster, AL) were used without further purification.
The reduction-sensitive lipid (Q-DOPE) was synthesized as described previously. Calcein,
KCl, K2HPO4, KH2PO4, Na2S2O4, Triton X-100, and 2-(cyclohexylamino)-ethanesulfonic
acid, CHES, were obtained from Sigma-Aldrich (St. Louis, MO). Sephadex G50 fine was
from GE Healthcare (Piscataway, NJ). Large unilamellar vesicles (LUVs) were produced by
extrusion;24 for details see Supporting Information.
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All fluorescence measurements were performed at 25 °C using a Perkin Elmer LS55
fluorescence spectrometer (Waltham, MA) with excitation at 490 nm (slit 2.5 nm) and
emission at 515 nm (slit 2.5 nm). The total intensity of emitted light was adjusted using
neutral density filters from Omega Optical (Brattleboro, VT). For the time-dependent
measurements, fluorescence intensity was measured in 1 min intervals.
Contents Release Assay
Calcein release assays were performed using a modified protocol,25 as outlined in the
Supporting Information.
Static Light Scattering at 90°
LUVs devoid of calcein were prepared as described above using pH 7.4 and 9.0 buffers.
Light scattering (5-s intervals) was measured at 90° with a Perkin Elmer LS55 fluorescence
spectrometer (Waltham, MA) following a protocol of Goldenbogen et al.8 Incident light was
600 nm, scattered light was recorded at 610 nm, and a slit width of 10 nm was used for both
the incident and scattered light.
Multiple-angle Light Scattering (MALS)
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LUVs devoid of calcein were prepared as described above using pH 7.4 and 9.0 buffers. To
examine shape changes induced by reduction, solid sodium dithionite (final concentration
~500 μM) was added to the sample, followed by gentle mixing prior to injection of the
sample into the measuring cell, where it remained under quiescent conditions. MALS was
performed using a Dawn Heleos (Wyatt Technology; Santa Clara, CA) equipped with a
GaAs Laser operating at a wavelength of 658 nm. Light intensity was recorded at 10 angles
(43.2°, 51.9°, 60.2°, 69.5°, 79.8°, 90.0°, 110.5°, 121.0°, 131.9°, 142.0°).
Analysis of MALS Data
Data was analyzed as described previously26 according to the Rayleigh-Gans-Debye (RGD)
theory. In brief, intensity values I(θ) measured at scattering angles θ divided by the intensity
measured at 90°, I(90°), were plotted against the scattering angle θ. The data points were
fitted to the RGD scattering factor P(q), where q=(4πn/λ)*sin(θ/2). Here, n is the refractive
index of the solvent, and λ is the wavelength of the incident light. For spherical vesicles,
P(q) is given by Equation 1:
(1)
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With j1(x) = sin x/x2−cos x/x, u is the outer radius of vesicle, and v is the inner radius of the
vesicle.

RESULTS AND DISCUSSION
Contents Release from Reduction-sensitive Liposomes
In a previous study, it was shown that (i) stable unilamellar vesicles can be made using the
reduction-sensitive quinone propionic acid lipid, Q-DOPE, 1a in Scheme 1;20 (ii) small,
water-soluble molecules such as calcein dye can be entrapped inside these vesicles; and (iii)
contents release can be triggered by dithionite reduction of the quinone head group to the
corresponding hydroquinone 1b, that in turn causes its rapid cyclizative removal to yield
DOPE 1c and the cyclized lactone 1d.20
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In Figure 1A are shown the time-dependent fluorescence emission traces at 515 nm for QDOPE vesicles initially containing calcein at concentrations of 40 mM (blue trace) and 80
mM (black trace) at pH 7.4 after addition of dithionite reducing agent. Although calcein
concentrations ≥ ~80 mM are typical for measuring its release,27 ~40 mM values are just as
well suited for release measurements and even more so for detecting variations of liposome
inner volume, because calcein fluorescence dequenching is highly sensitive to concentration
changes near 40 mM. However, the less efficient quenching at 40 mM results in a higher
initial fluorescence, but this does not impact the outcomes and their explanation for the
intensity variations we observe. As seen in Figure 1A, the fluorescence intensity remains
almost constant during the first minutes following addition of dithionite reducing agent.
About 12 min after addition of reducing agent, the fluorescence intensity first decreases over
a 2–3 min time period and then (15–25 min) increases to a level slightly higher than the
initial intensity. The decrease in calcein fluorescence at ~12 min is interpreted as being
caused by an increase in intraliposomal calcein concentration resulting from a deformation
or size contraction of the liposomes. Hence, the subsequent (15–25 min) increase in
fluorescence corresponds to a dilution of calcein resulting from a volume increase of the
LUVs, most likely due to a relaxation of the deformed/contracted vesicles caused by their
aggregation and subsequent interliposomal membrane interaction. The hypothesis of a
contraction followed by a relaxation step is supported by the “divot” in the fluorescence
intensity curves being more pronounced for the 40 mM calcein concentration.
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Approximately 28 min after dithionite addition, the observed abrupt and rapid fluorescence
increase that occurs over a period of 5 min is the burst-phase release30 of calcein. From here
forward, the period of time from dithionite addition until the start of the burst phase will be
referred to as the lag time or lag phase. Addition of the detergent Triton X-100 (up arrows in
Figure 1A) ensures complete rupture of any possible remaining liposomes, and for the time
points denoted in Figure 1A, virtually 100% of the entrapped calcein was released during the
5-min burst phase. Please note, the fluorescence traces of Figure 1A show the relative
fluorescence intensities of calcein instead of the calcein release (Figures 1B, 2, and 4) in
order to demonstrate the difference between the calcein release at 40 mM and 80 mM. The
initial fluorescence of Figure 1A (40 mM calcein encapsulated, pH 7.4) displays a relatively
high fluorescence intensity because calcein is not strongly quenched at a concentration of 40
mM compared to values of 80 mM or more;28, 29 the fluorescence intensities immediately
before and after the addition of dithionite are not significantly different, pointing to a lack of
calcein release.
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As a control, we added the non-reducing salt NaHSO3 to the Q-DOPE liposomes instead of
Na2S2O4; the fluorescence intensity remained constant; neither the fluorescence dip nor any
significant release was observed.20 In the absence of any added material, no observable
contents release occurred (Figure S3, lower panel, right).
Effect of TH on Calcein Release
We hypothesized in our previous work20 that burst-phase contents release from reduced QDOPE liposomes results from liposomal contact-mediated lysis, with the key event being
transition of DOPE lipids from the lamellar Lα to the HII phase that occurs when a critical
concentration of HII phase-competent lipid (DOPE) is formed in the outer leaflet.31 In order
to test this hypothesis, we investigated possible inhibition of contents release from the
reduced Q-DOPE liposomes at experimental temperatures Texp below or near TH of the
generated DOPE in two different ways: first, at room temperature and basic pH,32 the
surface of the resulting DOPE outer leaflet will be anionic and the TH of the DOPE will be
well above ambient temperature;33 second, at near neutral pH and 10 °C, the zwitterionic
DOPE will have its TH near this value.
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In Figure 1A is shown the time-dependent fluorescence intensity of calcein for reduced QDOPE vesicles at pH 9.0 (red) and pH 7.4 (blue). At pH 9.0, the fluorescence intensity
decreases rapidly 3 min after dithionite addition and is immediately followed by a
fluorescence increase between 3 and 5 min; this process is assigned as the deformation/
contraction phase. Then, an extremely slow efflux of calcein occurs over the next 120 min;
only 40% of the contents have been released 15 h later (Figure S1). This behavior is in clear
contrast to that noted at pH 7.4, where there is the dominant burst-phase contents release
(>95%) that is proceeded by the divot in the fluorescence trace associated with contraction/
deformation and subsequent relaxation of the liposomes. Similar behavior is noted for
reduced Q-DOPE vesicles at 10 °C and 25 °C with pH 7.4 (Figure S2 in the Supporting
Information). There is an exceedingly small amount of contents released from the liposomes
when the experimental temperature Texp is near the TH of DOPE (10 °C), while prompt
observation of near-quantitative, burst-phase calcein release occurs when Texp is above TH.
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Our observations can be explained by recognizing the selectivity of leaflet reduction, the
impact of pH and Texp on the lactone cyclization (Scheme 1) kinetics, and the influence of
experimental temperature on the rate of the Lα→HII phase change. As dithionite does not
cross lipid membranes,34 reduction of the quinone head groups and subsequent generation of
DOPE takes place in only the outer lipid leaflet. We attribute the monitored liposome
contraction to this lipid asymmetry (see Release Pathway discussion below). At pH 9.0 and
25 °C, the cyclization rate for hydroquinone group cleavage is greatly enhanced due to
catalysis by base.35 Also, head group cleavage is faster at pH 7.4 and 25 °C versus 10 °C as
judged by NMR kinetics.20, 36 Therefore, the lipid asymmetry-induced contraction/
deformation with its associated fluorescence decrease appears earlier at pH 9.0 than at pH
7.4 with Texp = 25 °C, as is true at pH 7.4 for Texp = 25 °C versus 10 °C. In addition, the
expected kinetically stable bilayer structure attained at pH 9.0 and Texp = 25 °C or pH 7.4
and Texp = 10 °C results in exceedingly slow calcein release. These outcomes agree with
those predicted by a contact-mediated lysis model of liposome opening,31 wherein contact
of the HII-competent outer leaflets of apposed bilayers of vesicles at temperatures above
TH—not mere aggregation of vesicles—leads to rupture of the bilayers.
Effect of Lipid Concentration on Release Kinetics
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To evaluate the interplay between vesicle-vesicle interactions (aggregation) and contents
release for Q-DOPE LUVs, we performed calcein release assays at different lipid (liposome)
concentrations. It has been shown that contents release from LUVs, caused by cleavage of
stabilizing lipids incorporated into LUV membranes composed mainly of DOPE, is
accompanied by concentration-dependent aggregation of the vesicles,7, 11, 12 an event
consistent with a liposome contact-mediated lysis mechanism. In Figure 1B is shown the
release of calcein at Q-DOPE lipid concentrations of 12.5–200 μM. The starting point for
the fluorescence decrease (beginning of the divot in fluorescence) at roughly 12 min is
relatively unaffected by lipid concentration, but the time point for subsequent recovery of
fluorescence intensity is delayed at Q-DOPE concentrations below 100 μM. While
fluorescence recovery begins at ~14 min for 100 and 200 μM Q-DOPE, it starts at ~16–17
min for 25 and 50 μM Q-DOPE, and 20 min for 12.5 μM Q-DOPE. As a consequence, the
depth of the divot in fluorescence intensity is more pronounced at lower lipid
concentrations.
The onset of the burst phase is shifted to later times by about 1 min for each lipid
concentration step from 200 μM to 25 μM. Importantly, the overall amount of released
calcein is unchanged. In contrast, at a Q-DOPE concentration of 12.5 μM, the burst phase
starts about 35–40 min after reduction of Q-DOPE, and after 80 min, only about 30% of the
calcein is released. In general, faster release kinetics at higher lipid concentrations
demonstrate the necessity of inter-vesicle contact for contents release, but do not provide
Langmuir. Author manuscript; available in PMC 2014 June 04.
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proof of vesicle aggregation subsequent to liposome opening. Perhaps, mere vesicle
collisions could be involved in the recovery of fluorescence before the burst phase, as well
as in the release of calcein. To determine the possible role of vesicle aggregation in the
triggered release of contents from reduced Q-DOPE LUVs and to test the hypothesis of
vesicle deformation/contraction prior to burst-phase release, we performed light scattering
measurements.
Size and Shape Changes of Q-DOPE Vesicles Observed by Static Light Scattering
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To maintain the experimental conditions of the calcein release assay, we first performed
static light scattering at 90° using a fluorescence spectrometer equipped to measure scattered
light. In contrast to the constant scattered light intensity observed for the Q-DOPE
liposomes at pH 7.4 and pH 9.0, addition of dithionite led to an increase in scattered light
intensity roughly 28 min (pH 7.4; Figure 2A, red) and 10 min (pH 9.0; Figure 2B, red) later
(in Figure S3, lower left panel, is shown the raw data of scattering at 90° before and after
reduction of the LUVs at pH 7.4 and pH 9.). Before the burst phase at pH 7.4 in Figure 2A, a
slight decrease in the scattering intensity (red) was observed at ~14 min that is coincidental
with the decrease in fluorescence (black) that we have attributed to a size decrease in/
deformation of the liposomes due to membrane asymmetry (vide supra). Simultaneous to the
burst-phase release of contents at ~28 min, the scattering intensity also increases sharply,
indicating significant vesicle aggregation. A similar scattering profile was found at pH 9.0
(Figure 2B, red), but it is shifted to earlier times than the pH 7.4 case, in agreement with the
faster base-catalyzed cyclization reaction (vide supra). Although the scattering intensity at
pH 9.0 rises sharply about 10 min after dithionite addition (Figure 2B; red), no significant
contents release was observed (black).
The light scattering results at pH 7.4 and pH 9.0 demonstrate that aggregation of reduced QDOPE vesicles, resulting from generation of DOPE in the proximal leaflets by the lactone
cyclization reaction, is not sufficient to induce contents release. At pH 7.4, vesicle
aggregation is correlated with the release of encapsulated molecules, whereas calcein
remains entrapped in the aggregated vesicles at pH 9.0 because the experimental
temperature is below that of the TH of diacylphosphatidylethanolamines,33, 37 thereby
inhibiting the Lα→HII phase transition.
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To obtain information about the size and shape of the Q-DOPE vesicles at pH 7.4 and pH
9.0 prior to and including the burst-phase release event, the time-dependent intensity of
scattered light was measured at 10 different angles (43.2°–142.0°) for vesicles in the
presence and absence of dithionite. Form factors derived from the Rayleigh-Gans-Debye,
RGD, approximation26, 38 were used. Prior to reduction, scattering intensities for the QDOPE LUVs at pH 7.4 and pH 9.0 were well fitted to a model based on spherical
unilamellar vesicles with a geometric radius of about 40 nm and a 4 -nm membrane
thickness,39 Figure 3 (measured data points: solid dots; fit: green line). Upon reduction of QDOPE LUVs, the time-dependent, multi-angle intensity traces of scattered light (Figure S3)
were similar in shape to those at 90° obtained with the fluorescence spectrometer, Figs. 2A
and 2B. To learn about the morphological nature of the contracted/deformed Q-DOPE LUVs
formed by dithionite reduction, determinations of the form factor in this time regime of the
experiment were carried out. The processed intensity data could not be fitted to form factors
based on spherical LUVs (Figure 3, open squares) for either pH, pointing to the presence of
non-spherical reduced Q-DOPE vesicles. Attempts to fit the data to a model having either
prolate or oblate vesicles were unsuccessful.
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In order to gain knowledge about the role of lipid composition on contents release from the
reduced Q-DOPE liposomes, we examined the behavior of Q-DOPE liposomes containing:
i) low mole ratios of a non-protein-fouling lipid, PEG-DOPE, similar to those commonly
used in liposomal drug delivery systems; ii) the inverted phase-competent lipid DOPE; and
iii) combinations of PEG-DOPE and DOPE.
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First, we explored the influence of PEGylated lipids on the release of calcein from Q-DOPE
liposomes. To this end, we prepared Q-DOPE LUVs with various amounts of PEGylated
DOPE (PEG2000-DOPE; Mr(PEG) = 2,000 Da). In Figure 4A are displayed representative
calcein release curves for reduced Q-DOPE liposomes containing 0.0%, 0.1%, 0.5%, and
3.0% PEG2000-DOPE. Liposomes with 0.0% and 0.1% PEG2000-DOPE (blue and black
lines) exhibit similar release curves. First, the fluorescence divot appears, as described
above. After a lag time of about 30 min, the burst phase for calcein release begins and is
more than 90% complete within ~10 min. When Q-DOPE liposomes contain 0.5% PEG2000DOPE (red line), the lag time and the onset time for the fluorescence divot are virtually
unchanged when compared to liposomes containing less PEG2000-DOPE. However, for the
0.5% PEG2000-DOPE/99.5% Q-DOPE LUVs, only 30% of their contents is released after
waiting twice as long before lysing them with Triton X-100. We attribute this lower level of
contents release to a stabilizing effect resulting from the presence of the PEG-DOPE lipids.
For 3% PEG-DOPE/97% Q-DOPE LUVs (green line), a very small amount of the contents
are released, although the size/shape change fluorescence divot is still observed during the
lag phase.
Influence of DOPE on Calcein Release from Reduction-sensitive Liposomes
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The influence of DOPE on the release of calcein from Q-DOPE liposomes was tested with
vesicles containing 0.0%, 3.8%, and 10.0% DOPE, Figure 4B. For 3.8% DOPE/96.2% QDOPE LUVs (black line), the burst phase appeared 10 min earlier than for 100% Q-DOPE
LUVs (blue line), and some calcein release was also observed prior to the burst phase. In
LUVs with 10% DOPE (red line), the burst phase started 1–2 min earlier. For fruitful
contact-mediated lysis of the reduced Q-DOPE LUVs, a critical concentration of DOPE
must first be generated by cyclization of the reduced quinone so that successful apposed
bilayer contact and the subsequent Lα→HII phase transition take place. For the DOPE/QDOPE LUVs, this critical DOPE concentration in the membrane is reached earlier, thereby
allowing for earlier release of their cargo. Furthermore, the fluorescence profile during the
lag phase was changed for the DOPE/Q-DOPE LUVs. When 0% or 3.8% of DOPE is
present in the membrane, the fluorescence divot is observed in the first 15 min (for 3.8%
DOPE) to 20 min (for 0% DOPE) before the burst phase starts. For 10% DOPE/90%QDOPE liposomes, the divot before the burst phase is not readily apparent, as only a slight
decrease in calcein fluorescence is observed during the lag phase. This outcome indicates a
change in the contents release pathway when moving from vesicles containing 0% or 3.8%
DOPE to vesicles with 10% DOPE, as discussed later.
We investigated the release of calcein from Q-DOPE vesicles containing both PEG2000DOPE and DOPE. For 0.5% PEG2000-DOPE, we found the combined effects of both
additional lipids: a decreased amount of contents release caused by PEG2000-DOPE and
faster release kinetics, as well as an altered release pathway, due to DOPE. Interestingly, we
could partially regain larger release rates applying DOPE concentrations of 10% and higher,
that is, when the release pathway is changed as a consequence of the high DOPE
concentrations (Figure S4 and accompanying text in the Supporting Information).
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Combining our observations with previously published results, the process of reductioninduced contents release from Q-DOPE liposomes can be posited, Scheme 2. The addition
of dithionite leads to rapid reduction of the quinone groups40 situated only on the outer
leaflet, due to its inability to pass the anionic lipid bilayer.34 As a consequence, DOPE is
formed on only the outer leaflet, and thus the outer and inner portions of the bilayer exhibit
different lipid compositions (Scheme 2, phase “reduction and cleavage”). When the
contraction phase starts at ~12 min, as indicated by the decreased calcein fluorescence and
our light scattering data, about 20% of the hydroquinone moieties have been cleaved to yield
the critical amount of outer leaflet DOPE to begin the vesicle deformation/size decrease.20
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To explain the shape/size change of the LUVs associated with the fluorescence divot, at
least two different effects may play a role. First, a change in the spontaneous curvature of
the membrane has to be considered.41 In a simplistic model, the phase behavior,42 as well as
the curvature of lipid bilayers,43 can be connected to the molecular shape of the lipids. Due
to its ability to form stable bilayers, Q-DOPE must exhibit a cylindrical shape. Cleavage of
the quinone head group only in the outer leaflet generates DOPE, an inverted cone-shaped
lipid, whose presence induces a more negative curvature only in the outer leaflet. The
differences in spontaneous curvature of the inner and outer leaflets lead to deformation/
contraction of the vesicles. Alternatively, according to the area-difference elasticity (ADE)
model,44 area differences between lipid membrane leaflets determine their morphology.
Heuvingh and Bonneau45 recently reported on the induced deformation of giant unilamellar
vesicles (GUVs) made of dioleoylphosphatidylcholine. In their work, use of a chemical
reaction selective for a given lipid leaflet led to budding of new vesicles inside or outside of
the GUVs. Inward budding resulted when the chemical reaction led to a lower total area for
the outer leaflet. Analogous to their observations, we propose that reductive cleavage of the
bulky quinone head group lowers the area of the outer leaflet, causing deformation of the
vesicles. Before the burst-phase release of calcein, the recovery of fluorescence in the divot
was shown to be dependent on lipid concentration. Therefore, this phenomenon is connected
to interactions between liposomes. Although we cannot give a conclusive explanation at this
time, preliminary results suggest that hemifusion of deformed liposomes is involved in
relaxation of the shape of the deformed LUVs and, thus, in an increase of the inner volume
of the liposomes. This view is supported by experiments showing that hemifusion is favored
in phosphatidylethanolamine-containing lipid membranes.43 An upcoming paper will
address these new findings regarding hemifusion. Subsequently, aggregation of reduced QDOPE vesicles takes place during the burst phase and is necessary for the subsequent
contents release at pH 7.4, because the associated release kinetics are strongly reduced at
low lipid concentrations, Figure 1B. These observations are in accord with those for pHsensitive liposomes wherein aggregation was necessary before their contents were released.
Suppression of contents release from reduced Q-DOPE LUVs at pH 9.0 (TH > ambient),
along with their demonstrated aggregation, demonstrates that the deformation and
aggregation events are not sufficient to cause burst-phase contents release; it is necessary to
have a non-bilayer competent lipid composition comprising the outer leaflet. That is to say,
not only must there be present in the proximal leaflet a sufficient amount of non-bilayer
prone lipid, but also the experimental temperature must be above that for the Lα→HII
transition. Thus, the cause of the burst phase at pH 7.4 is the structural rearrangement of the
lipids during the events leading up to and including the Lα→HII transition for a membrane
enriched in DOPE.32 Based on the kinetics of reduced quinone cleavage20 at pH 7.4, the
outer leaflet contains roughly 50% DOPE at burst-phase onset.
Some remarks about the vesicle aggregation and leakage at pH 9.0 may complete our
thoughts on the release mechanism. When pure diacylphosphatidylethanolamine liposomes
are prepared at a high pH (≥ 9), usually no time-dependent aggregation or significant
Langmuir. Author manuscript; available in PMC 2014 June 04.
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contents release is observed. For instance, Ellens et al.32 investigated the destabilization of
different diacylphosphatidylethanolamine liposomes caused by temperature, pH, and
presence of Ca2+ via measurement of aggregation and contents release. At pH 9.5, they
found no transient aggregation, but stated that the size of the liposomes exceeds the value
for other negatively charged liposomes produced with the same method; they conclude that
the liposomes are initially oligomeric, that is, preaggregated prior to subsequent triggered
release/aggregation measurements. In the case of Q-DOPE vesicles, the LUVs are not
preaggregated before the reduction at pH 9.0, as it can be concluded from size
measurements via dynamic light scattering; but the generation of DOPE leads to aggregation
and an enhanced light scattering. Moreover, the slight release we observe at pH 9.0 is also in
agreement with the results of Ellens et al.32 At a low pH (<7), a significant release below the
TH was found for all tested PE vesicles;32 at pH 9.5 the release was “less than 1%/min,”
similar to our findings. The average leakage from Q-DOPE vesicles 1000 min after
reduction was about 0.04%/min. Besides that work, other attempts to encapsulate dyes into
PE liposomes have repeatedly failed.46, 47 In summary, the leakage from Q-DOPE vesicles
at pH 9.0 can be attributed to the destabilization of the membrane caused by the high
amounts of DOPE on the outer leaflets although no apparent phase transition occurs.
Possibly the strong transverse lipid asymmetry also plays an important role.
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We are aware that further experiments, e.g. detailed cryogenic transmission electron
microscopy to track the morphology transitions of the vesicles, have to be performed to
provide additional support for this hypothesis. Nevertheless, the proposed release pathway
does not only fit well to the data presented here, but it also agrees with results from other
groups that tested the release mechanism of liposomal systems that rely on the generation of
an unstable lipid membrane in the context of the dependency of lipid vesicle aggregation on
lipid concentration, as well as the need for a critical amount of stabilizing lipids that have to
be cleaved to induce the process of contents release.7, 12 Moreover, our model is well suited
to explain the dependency of release kinetics and overall release of entrapped molecules on
the presence of PEG-DOPE and DOPE in Q-DOPE liposomes, to which we next turn.
Influence of PEG-DOPE and DOPE on Contents Release and Pathway
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We found that adding DOPE to Q-DOPE liposomal compositions led to two effects that
alter the kinetics of calcein release and the release pathway. In the presence of 3.8% DOPE,
it was found that liposome contraction/deformation, relaxation, and burst-phase contents
release occur earlier than for cases of lower DOPE concentration, because less DOPE has to
be generated in the liposomes to reach the critical amount of DOPE required to induce these
processes. These outcomes are in agreement with the model in Scheme 2. When 10% DOPE
was incorporated into the membranes, the release kinetics are only slightly altered compared
to that found for 3.8% DOPE, but the contraction/deformation and relaxation processes are
not apparent. To explain this change in the calcein fluorescence trace for the 10% DOPE
liposomes, one has to take into account the proposed release pathway in Scheme 2. The
suggested deformation of the liposomes due to lipid asymmetry between the inner and outer
membrane leaflets is caused by the formation of DOPE in the outer lipid layer. However,
when a defined, sufficient amount of DOPE is also present in the inner leaflet, the difference
in spontaneous curvatures of the inner and outer leaflets is not significant enough to lead to a
shape change of the membrane, Figure 4B.
In contrast, the kinetics of liposomal contents release were not affected by the presence of
PEG2000-DOPE up to the maximum amount investigated, 3.0% (see Figure 4A). Neither the
starting point of liposome deformation/contraction, nor the time for the “relaxation” and the
burst-phase release were altered significantly. However, the fraction of initially encapsulated
calcein that was released was found to decrease from over 90% released (0%, 0.1%
PEG2000-DOPE), to 30% (0.5% PEG2000-DOPE), and about 5–15% (3% PEG2000-DOPE).
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First, it has to be mentioned that the concentrations of PEG2000-DOPE applied in this study
are below the amount necessary for transition from the mushroom to brush regime.48 Thus,
differences concerning the calcein release are not related to conformational changes of the
PEG chains.
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The influence of PEGylated lipids on the induced release of molecules from liposomes has
been explored in various studies of pH-sensitive liposomes,17, 18, 49 where it was found that
a decreased amount of contents was released. Other investigations also revealed a decreased
level of contents release due to the presence of PEG lipids, particularly for dehydrationinduced50 and melittin-initiated leakage51 of liposomes. The lower level of release was
attributed to steric effects of the PEGylated lipids that hinder the required liposomal
aggregation (dehydration-induced release) and stabilization of lamellar lipid structures
(dehydration-induced and melittin-initiated release). In addition, conclusions about the
influence of PEG lipids on triggered contents release can be drawn from studies of
liposomal fusion. Similar to triggered liposomal release resulting from generation of HIIprone lipids, the mechanism of fusion relies on aggregation of liposomes overcoming the
hydration barrier and the ability of the lipid mixture to undergo an Lα to HII phase transition.
Moreover, fusion events are mostly accompanied by leakage. Holland et al. observed an
inhibition of Ca2+-induced fusion of phosphatidylserine-containing liposomes caused by
PEGylated dimyristoylphosphatidylethanolamine;52 in that study, the effect was attributed to
the steric barrier provided by the PEG head group that prevented interliposomal bilayer
contact. A study by Basáñez et al. gives detailed insights into the influence of PEGylated
distearoylphosphatidylethanolamine, DSPE, on phospholipase C-triggered fusion.53 They
found that the use of increasing amounts of PEG-DSPE (Mr(PEG)=2,000) led to slower
rates of aggregation, and lipid and contents mixing. Steric repulsion between apposed PEG
head groups hindered aggregation of liposomes containing more than 0.1% PEG-DSPE.
Furthermore, lipid and contents mixing—events representing complete liposomal fusion—
were inhibited at PEG-DSPE concentrations of 0.1–0.5%, with the decreased lipid/contents
mixing being proposed to be due to a stabilization of the lamellar phase.
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Stabilization of the lamellar phase and inhibition of liposomal contact formation are two
possible explanations for the effects of PEG2000-DOPE on contents release from Q-DOPE/
PEG2000-DOPE liposomes. If inhibition of liposome aggregation were the reason, one
would expect to see a delay in onset of the burst phase; however, this was not observed in
any case in our studies. Therefore, we exclude the possibility of PEG2000-DOPE influencing
inter-vesicle contacts with the use of 0.1–3.0% of PEG2000-DOPE in the Q-DOPE LUVs.
Importantly, the observed decrease in contents release can be well explained with the known
ability of PEG-PE to stabilize the lamellar phase of HII-prone lipid mixtures.54 For instance,
in mixtures of DOPE and PEG-DSPE (Mr = 2,000), a PEG-DSPE content of 8% was
sufficient for the formation of a pure lamellar phase at 20 °C.55 In contrast, several thiolyticand pH-sensitive liposomal systems rely on the cleavage of PEG moieties from lipid
membranes to generate non-bilayer structures so as to achieve release of encapsulated
molecules; it was shown that liposome contents were not released until the amount of PEG
lipid in the membrane dropped below 2.3%–3%.9, 55 In the work at hand, when triggered
contents release from Q-DOPE vesicles containing PEG2000-DOPE occurs, the amount of
PEG2000-DOPE in the membrane remains constant. Thus, upon aggregation of these
liposomes, PEG2000-DOPE has to be excluded (moved) from liposomal contact areas due to
steric arguments, and the lipid bilayer outside of the contact areas becomes enriched in
PEGylated lipid. As a result, after a defined, critical concentration of PEG2000-DOPE is
attained in this “non-aggregation” membrane area, stable lamellar structures are formed that
prevent further efflux of calcein. Our data shows that full inhibition of contents release from
reduced Q-DOPE liposomes is achieved when between 0.5% and 3.0% of PEG2000-DOPE is
present.
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Finally, the kinetics of contents release, and the total amount of contents released, can be
controlled by using Q-DOPE formulations containing both PEG2000-DOPE and DOPE.
When 0.5% PEG2000-DOPE is present in the vesicles, the total amount of contents released
can be substantially augmented by incorporating DOPE in the LUVs, pointing to a possible
change in the release pathway. Therefore, the results provide clues for future efforts in the
rational design of a drug delivery system that has both long circulation times and an efficient
release at the target site.
Impacts on Drug Delivery Systems
For the delivery of drug molecules to targets inside cells, these molecules must pass cellular
membranes (plasma membrane or after uptake, the endosomal membrane). To overcome this
obstacle, triggerable liposomes can be designed to fuse with the target membrane. For pHsensitive liposomes, it was shown that they are able to fuse after activation, but only with
other pH-sensitive liposomes and not with other (not pH-sensitive) membranes.56 Moreover,
preliminary studies on reduced Q-DOPE liposomes provide no support for the fusion of
these vesicles. To achieve a fusiogenic behavior of Q-DOPE membranes, the formulation of
the liposomes can be altered. While the generated DOPE promotes hemifusion—an accepted
precursor of fusion—cone-shaped lipids such as lysolipids or fatty acids are known to
induce full membrane fusion.57 An alternative approach may include the use of fusogenic
peptides.58
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Using a PEG2000-PE concentration of 3% or more in Q-DOPE liposomes, a value typical for
drug delivery systems so as to suppress their clearance by the reticuloendothelial system,
will abolish the redox-triggered release from Q-DOPE vesicles. Even the incorporation of
50% DOPE into Q-DOPE liposomes containing 3% PEG2000-PE did not restore high release
values. However, PEGylated PE itself represents a sheddable coating for liposomes: PEG
lipids can diffuse out of the membrane and will insert into acceptor membranes if present
(see reference 5959 and references therein), i.e. liposomes not containing PEG lipids or
cellular membranes. The kinetics of this process are dependent on the chain length and
saturation level of the lipid anchors. For instance, PEG2000-DOPE, bearing monounsaturated
lipid chains, has been proven to exchange into acceptor membranes, while PEG2000distearoyl-PE having saturated lipids was not extracted from the donor membrane in the
observed time frame.60 Hence, PEG2000-DOPE might be well suited to shield Q-DOPE
liposomes for the time it needs to reach the target while its concentration is lowered during
circulation. A suppressed payload release by small amounts of PEG2000-PE remaining in the
Q-DOPE vesicles might then be overcome by the incorporation of DOPE into the membrane
of the liposome, as we have found for Q-DOPE vesicles containing 0.5% PEG2000-DOPE
and 10 to 21% DOPE.
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Figure 1.

(A) Fluorescence of calcein during release from Q-DOPE liposomes at pH 7.4 containing 40
mM (blue) and 80 mM (black) calcein after the addition of sodium dithionite, as well as
from liposomes containing 40 mM calcein at pH 9.0 (red). (B) Release of calcein from
reduced Q-DOPE liposomes at different lipid concentrations. Measurements were performed
at an initial encapsulated calcein concentration of 40 mM. Arrows indicate the addition of
Triton X-100 to yield 100% calcein release.
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Figure 2.

Scattered light (red) and fluorescence intensity (black) for reduced Q-DOPE liposomes
containing calcein at (A) pH 7.4 and (B) pH 9.0. Calcein release and light scattering
experiments were both performed with the same fluorescence spectrometer and cuvettes.
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Figure 3.

Intensities of scattered light of Q-DOPE vesicles measured at different angles divided by the
intensity at 90° (squares, circles), as well as the calculated form factor P(θ)/P(90°) (lines)
plotted against scattering angle θ. Measured intensity of Q-DOPE vesicles at pH 9.0 before
(filled circles) and 5 min after the addition of dithionite (hollow squares). Applying form
factors for spherical unilamellar vesicles, the radius of LUVs could be fitted to about 40 nm
(red line). Reduced Q-DOPE vesicles could not be fit to this model.
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Figure 4.

(A) Calcein release curves from reduced Q-DOPE LUVs containing 0.0%, 0.1%, 0.5%, and
3.0% PEG2000-DOPE. (B) Calcein release from reduced Q-DOPE liposomes containing
0.0%, 3.8 %, and 10.0% DOPE. Arrows indicate the time when Triton X-100 was added to
lyse any possible remaining LUVs.
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Scheme 1.

Reduction-initiated cleavage of Q-DOPE 1a. The hydroquinone intermediate 1b undergoes
an intramolecular cyclization reaction to yield the inverted-phase-forming DOPE 1c and the
cleaved lactone 1d. R = C18H33O.
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Scheme 2.
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Proposed pathway for contents release from reduced Q-DOPE liposomes.
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